Table 2

Clinical characteristics of study patients (N = 225)

Variable

n (%)


Stage (n = 214)

I

40 (18.7)

II

113 (52.8)

III

53 (24.8)

IV

8 (3.7)

T (n = 222)

T1

59 (26.6)

T2

106 (47.7)

T3

27 (12.2)

T4

30 (13.5)

N (n = 222)

N0

94 (42.3)

N1

112 (50.5)

N2-3

16 (7.2)

Grading (n = 220)

G1/G2

151 (68.6)

G3

69 (31.4)

Histology (n = 225)

Ductal

175 (77.8)

Lobular

22 (9.8)

All other subtypes

28 (12.4)

Menopausal (n = 163)

Premenopausal

43 (26.4)

Postmenopausal

120 (73.6)

ER (n = 212)

Positive

135 (63.7)

Negative

77 (36.3)

PR (n = 211)

Positive

127 (60.2)

Negative

84 (39.8)

Metastasis (n = 218)

Negative

210 (96.3)

Positive

8 (3.7)


ER, estrogen receptor; N, palpable nodes; PR, progesterone receptor; T, tumor size.

Fritz et al. Breast Cancer Research 2005 7:R374-R384   doi:10.1186/bcr1012

Open Data